KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells

Johnny T. Stine(Kanazawa University), Christi L. Wood(Kanazawa University), Mark S. Hill(Kanazawa University), Angela Epp(Kanazawa University), Carol J. Raport(Kanazawa University), Vicki L. Schweickart(Kanazawa University), Yoshio Endo(Kanazawa University), Takuma Sasaki(Kanazawa University), Graham Simmons(Kanazawa University), Chris Boshoff(Kanazawa University), Paul R. Clapham(Kanazawa University), Yuan Chang(Kanazawa University), Patrick S. Moore(Kanazawa University), Patrick W. Gray(Kanazawa University), David Chantry(Kanazawa University)
Cited by 212

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) encodes 3 genes that are homologous to cellular chemokines. vMIP-III, the product of open reading frame K4.1, is the most distantly related to human chemokines and has yet to be characterized. We have examined the interaction of vMIP-III with chemokine receptors, its expression in KS lesions, and its in ovo angiogenic properties. We show expression of vMIP-III in KS lesions and demonstrate the stimulation of angiogenesis by this chemokine, like vMIP-I and vMIP-II, in the chick chorioallantoic membrane assay. vMIP-III does not block human immunodeficiency virus entry through the coreceptors CCR3, CCR5, or CXCR4. However, vMIP-III is an agonist for the cellular chemokine receptor CCR4. CCR4 is expressed by TH2-type T cells. Consistent with this, vMIP-III preferentially chemoattracts this cell type. Because of these biologic properties and because it is expressed in KS lesions, vMIP-III may play an important role in the pathobiology of KS. (Blood. 2000;95:1151-1157)


Related Papers

No related papers found

Powered by citation graph analysis